Alan Dunton

Alan Dunton

Direktör/Styrelseledamot på CORMEDIX INC.

Förmögenhet: 595 501 $ per 2026-05-31

71 år
Health Technology
Consumer Services
Commercial Services

Profil

Dr. Alan W.
Dunton
, MD, is an Independent Non-Executive Director at Recce Pharmaceuticals Ltd., an Independent Director at CorMedix, Inc., an Independent Director at Palatin Technologies, Inc. and an Independent Director at Oragenics, Inc. He is on the Board of Directors at Recce Pharmaceuticals Ltd., CorMedix, Inc., Cytogel Pharma LLC, Palatin Technologies, Inc., Oragenics, Inc. and ActivBiotics, Inc. Dr. Dunton was previously employed as an Independent Non-Executive Director by Regeneus Ltd., a SVP-Regulatory Affairs, Research & Development by Purdue Pharma LP, a Non-Executive Director by Bionomics Ltd., a Chief Medical Officer by Derma Sciences, Inc., a Non-Executive Chairman by EpiCept Corp., a Chief Medical Officer by Marina Biotech, Inc., a Managing Director by Panacos Pharmaceuticals, Inc., an Independent Director by Targacept, Inc., a Principal Owner by Danerius LLC, a President & Chief Executive Officer by Metaphore Pharmaceuticals, Inc., a President, Chief Operating Officer & Director by Emisphere Technologies, Inc., a President & Managing Director by The Janssen Research Foundation, a Senior Executive by Johnson & Johnson, a Vice President-Clinical Research & Development by Syntex Corp., a Vice President-Clinical Research & Development by Ciba-Geigy Corp., a Vice President-Clinical Research & Development by Hoffmann-La Roche, Inc., a Chairman by Janssen-Cilag International NV, He received his undergraduate degree from State University of New York at Buffalo and a doctorate degree from New York University School of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-04-13 40 250 ( 0,05 % ) 339 710 $ 2026-05-31
2025-12-09 14 081 ( 0,79 % ) 197 416 $ 2026-05-31
2025-06-30 146 288 ( 0,05 % ) 57 889 $ 2026-05-31
2026-04-30 802 ( 0,02 % ) 486 $ 2026-05-31

Aktiva positioner av Alan Dunton

FöretagPositionStart
CORMEDIX INC. Direktör/Styrelseledamot 2019-03-01
ORAGENICS, INC. Direktör/Styrelseledamot 2011-04-01
PALATIN TECHNOLOGIES, INC. Direktör/Styrelseledamot 2011-06-22
RECCE PHARMACEUTICALS LTD Direktör/Styrelseledamot 2020-07-14
Direktör/Styrelseledamot 2018-10-01
Direktör/Styrelseledamot 2007-01-01

Tidigare kända positioner av Alan Dunton

FöretagPositionSlut
REGENEUS LTD Direktör/Styrelseledamot 2021-02-25
Teknisk/Vetenskaplig/F&U Direktör 2018-03-01
ADHERA THERAPEUTICS, INC. Teknisk/Vetenskaplig/F&U Direktör 2017-02-21
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Alan Duntons erfarenhet

Alan Duntons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

71

Första gradens relationer

34

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

The Janssen Research Foundation

R.W. Johnson Pharmaceutical Research Institute

Danerius LLC

Commercial Services

Johnson & Johnson Pharmaceutical Group

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Alan Dunton
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU